Kidney involvement in COVID-19 and rationale for extracorporeal therapies
Claudio Ronco, Thiago Reis, Claudio Ronco, Thiago Reis
Abstract
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19.
Conflict of interest statement
In the past 3 years, C.R. has been a consultant or advisory board member for ASAHI, Astute, Baxter, Biomerieux, B. Braun, Cytosorbents, ESTOR, Fresenius Medical Care, General Electric, Medtronic and Toray. In the past 3 years T.R. has been a consultant or advisory board member for Baxter, B. Braun and Eurofarma.
References
- Ministero della Salute. Covid-19. Situazione in Italia. Ministero della Salute. (2020).
- Guan W-j, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032.
- Neelapu SS, et al. Chimeric antigen receptor T cell therapy — assessment and management of toxicities. Nat. Rev. Clin. Oncol. 2018;15:47–62. doi: 10.1038/nrclinonc.2017.148.
- Wu C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020 doi: 10.1001/jamainternmed.2020.0994.
- Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.
- Girardot T, Schneider A, Rimmelé T. Blood purification techniques for sepsis and septic AKI. Semin. Nephrol. 2019;39:505–514. doi: 10.1016/j.semnephrol.2019.06.010.
- Ronco C, Reis T, De Rosa S. Coronavirus epidemic and extracorporeal therapies in intensive care: si vis pacem para bellum. Blood Purif. 2020 doi: 10.1159/000507039.
- Panitchote A, et al. Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann. Intensive Care. 2019;9:74. doi: 10.1186/s13613-019-0552-5.
- Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am. J. Respir. Crit. Care Med. 2016;194:402–414. doi: 10.1164/rccm.201602-0420CP.
- Klein DJ, et al. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44:2205–2212. doi: 10.1007/s00134-018-5463-7.
Source: PubMed